Market Research Logo

Uveitis Treatment Market, by Treatment, Disease Type, Cause, and Region - Trends and Forecast to 2025

Uveitis Treatment Market, by Treatment, Disease Type, Cause, and Region - Trends and Forecast to 2025

Uveitis refers to an autoimmune eye disease that causes inflammation in the uvea of the eye. Uveitis is considered to be one of the leading cause of blindness in the U.S. According to the Ocular Immunology and Uveitis Foundation in 2016, Uveitis is the third leading cause of blindness in the U.S. having affecting approximately 38 cases per 100,000 population. The three common types of uveitis are anterior uveitis (swelling of the uvea towards the front of the eye), intermediate uveitis (swelling in the middle of the eye), and posterior uveitis (swelling of the uvea towards the back of the eye). Panuveitis refers to a case in which all three areas of the eye are affected by inflammation. The most common type among the three is the anterior uveitis.
Market Dynamics
Major factors driving growth of the global uveitis treatment market include rising incidence of uveitis and complications associated with the disease. According to a survey published in research journal of JAMA Ophthalmology, non-infectious uveitis was reported in 121 cases per 100,000 adults and 29 per 100,000 children in 2016. Various other factors supporting the market growth include rising expenditure in research and development for new therapies to treat uveitis as well as speedy approvals from U.S. FDA for the drugs in pipeline to treat the condition. However, factors such as irreversible blindness in some cases due to side effects of medications and other such medical conditions can thus, hinder the market growth for global uveitis treatment. The side effects associated with corticosteroids include high blood pressure, kidney damage, skin disorders, and others.
Key features of the study:

This report provides in-depth analysis of uveitis treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the uveitis treatment Market

Detailed Segmentation:

Global Uveitis Treatment Market, By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

Global Uveitis Treatment Market, By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

Global Uveitis Treatment Market, By Cause:

Infectious Uveitis
Non-Infectious Uveitis

Global Uveitis Treatment Market, By Geography:

North America

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

U.S.
Canada

Europe

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Latin America

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

GCC
Israel
Rest of Middle East

Africa

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

South Africa
Central Africa
North Africa

Company Profiles

AbbVie, Inc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Novartis AG
Eyegate Pharmaceuticals, Inc.
Santen Pharmaceuticals
Alimera Sciences
Regeneron Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Allergan Plc

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet By Treatment
Market Snippet By Disease Type
Market Snippet By Cause
Market Snippet By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Pipeline Analysis
Novel Innovation in Uveitis Treatment
Epidemiology
4. Global Uveitis Treatment Market, By Treatment, 2017 – 2025, (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Immunosuppressant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Cycloplegic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Antivirals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Antifungal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Uveitis Treatment Market, By Disease Type, 2017 - 2025, (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Anterior Uveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Posterior Uveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Intermediate Uveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Panuveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Uveitis Treatment Market, By Cause, 2017 - 2025, (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Infectious Uveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
Non- infectious Uveitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Bone Graft and Substitutes Market, By Region, 2017 – 2025, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2017 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2017 - 2025
North America
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
Brazil
Mexico
Rest of Latin America
Europe
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
Santen Pharmaceutical Co., Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Regeneron Pharmaceuticals, Inc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Allergan Plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Valeant Pharmaceutical International, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Abbvie, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Alimera Sciences
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 35 market data tables and 30 figures on “Global Uveitis Treatment Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report